GBA1 and Parkinson disease: Glucosylceramide and sphingomyelin fractions in PD patients with distinct types of GBA genotypes, e.g., wild-type GBA allele, GBA risk variants, mild mutations, and severe GBA mutations (see “Methods” sections for detail), are shown in Fig. 2.